Investigators evaluated 12-month safety, efficacy of once-daily preservative-free carbachol 2.75%/brimonidine tartrate 0.1% ...

Funding supports the commercial product development of VisioLite® Device and Laser Scleral Microporation Human Clinical Study. Capital raised to date provides strong financial position to prepare the ...